ARTICLE | Company News
Imprimis, Buderer Drug deal
June 24, 2013 7:00 AM UTC
Imprimis acquired rights to undisclosed IP from compounding pharmacy Buderer and received a right of first refusal for additional IP. Imprimis said the undisclosed IP could lead to up to three develop...